Tradestie Institutional Equity Comparison Engine

NMTC vs RCEL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RCEL Overall Edge

RCEL Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus RCEL at 10.3x Forward P/E and -33.9% operating margin (+53.1% YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RCEL
NMTC N/M vs RCEL 10.3x Fwd P/E
Growth & Margin Winner RCEL
Op Margin -63.4% vs -33.9% ยท YoY +16.3% vs +53.1%
Momentum & Technical Winner RCEL
1Y +3.5% vs +295.4% ยท 52W Pos 2% vs 82%
Options & Structure Winner RCEL
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
NMTC NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
1M Return -33.46%
1Y Return +3.49%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0
RCEL NASDAQ
Avita Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.62
-2.31% 1D
Market Cap $506.7M
1M Return +1.3%
1Y Return +295.44%
Forward P/E 10.3x
Unified AI Score
45.6 / 100 HOLD
Tech 32.0 Fund 44.0 Flow 69.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMTC +3.49% RCEL +295.44% Spread: +291.95 pp (RCEL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NMTC Revenue RCEL Revenue NMTC Op. Margin RCEL Op. Margin Margin Edge
FY2018 N/A $0M N/A -1489.9% RCEL
FY2019 N/A $10M N/A -466.4% RCEL
FY2020 N/A $10M N/A -299.2% RCEL
FY2021 $0M $30M -5735.9% -90.8% RCEL
FY2022 $0M $30M -5860.2% -79.9% RCEL
FY2023 $0M $50M -612.3% -85.1% RCEL
FY2024 $0M $60M -344.3% -88.1% RCEL
FY2025 $10M $70M -46.5% -59.4% NMTC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMTC (1) vs RCEL (8)
Institutional Metric NMTC RCEL Criterion Row Winner
Market Capitalization Scale $6.1M $506.7M Larger Scale RCEL
Trailing P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Forward P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Revenue Growth (YoY) Growth +16.3% +53.1% Higher Growth RCEL
Operating Margin (TTM) Profitability -63.4% -33.9% Higher Margin RCEL
Net Profit Margin Profitability -59.7% -42.6% Higher Margin RCEL
Return on Equity (ROE) Capital Efficiency -124.7% -1746.3% Higher ROE NMTC
52-Week Range Position Momentum 2% ($1โ€“$5) 82% ($3โ€“$18) Stronger Trend RCEL
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 105% Vol 1.54ฮฒ ยท 65% Vol Lower Realized Risk RCEL
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 45.6 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMTC vs RCEL Buy Guide
NMTC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RCEL CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live RCEL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMTC nor RCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.